Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 92 (1), 11-15
- https://doi.org/10.1016/s0002-9149(03)00456-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in hearttransplant recipientsTransplantation Proceedings, 2002
- Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis DrugsCirculation, 2001
- Heparin Infusion Prior to Stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasiaAmerican Heart Journal, 2000
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Pathophysiology and treatment of lipid perturbation after cardiac transplantationCurrent Opinion in Cardiology, 1997
- Early Endothelial Dysfunction Predicts the Development of Transplant Coronary Artery Disease at 1 Year PosttransplantCirculation, 1996
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionNew England Journal of Medicine, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantationThe American Journal of Cardiology, 1990